Nippon India Nifty Pharma ETF
Direct · Growth ₹26.50
26 Oct 2026
NAV
20.3%
3Y CAGR
13.5%
5Y CAGR
16.1%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
11.21
Sharpe
-21.0%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
0.21%
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.56 L | 18.0% | -26.7% | 75.3% |
| 3 Years | ₹36.00 L | ₹47.47 L | 21.5% | 9.4% | 36.3% |
| 5 Years | ₹60.00 L | ₹94.33 L | 18.4% | 16.0% | 20.3% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | Category avg |
|---|---|---|
| 1 Year | 18.0% | 10.7% |
| 3 Years | 21.5% | 13.8% |
| 5 Years | 18.4% | 13.2% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 16.6% | 13.2% | -15.3% | 65.2% | 0.48 | 1.39 | 74% | — | — |
| 3 Years | 20.3% | 20.5% | 12.3% | 27.7% | 4.93 | — | 100% | — | — |
| 5 Years | 13.5% | 13.4% | 12.4% | 14.7% | 11.21 | — | 100% | — | — |
-21.0%
Max Drawdown
18 mo
Drawdown Duration
5 mo
Recovery Time
-6.6%
Avg Drawdown
Calmar Ratio by Duration
0.79
1Y
0.97
3Y
0.64
5Y
19
Total Holdings
78.2%
Top 10 Weight
1
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 19.50% |
| 2 | Divi's Laboratories Limited | 11.97% |
| 3 | Laurus Labs Limited | 7.82% |
| 4 | Cipla Limited | 7.68% |
| 5 | Dr. Reddy's Laboratories Limited | 7.62% |
| 6 | Torrent Pharmaceuticals Limited | 7.16% |
| 7 | Lupin Limited | 5.00% |
| 8 | Aurobindo Pharma Limited | 4.69% |
| 9 | Glenmark Pharmaceuticals Limited | 3.56% |
| 10 | Alkem Laboratories Limited | 3.16% |